Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.04. | Filament Health reports FY results | 1 | Seeking Alpha | ||
03.04. | Filament Health To Discuss Its Drug Development Platform In Fireside Chat With Water Tower Research On April 4, 2024 At 12pm Et | 1 | CNW | ||
03.04. | Filament Health Corp: Filament talks PEX010, omits 2023 P&L from NR | 1 | Stockwatch | ||
03.04. | Filament Health Reports Q4 And Year End 2023 Financial Results And Operational Highlights | 1 | CNW | ||
28.03. | Filament Health Corp: Filament appoints Messinger director, audit chair | 1 | Stockwatch | ||
28.03. | Filament Health Announces Appointment Of Michael Messinger To Its Board Of Directors | 1 | CNW | ||
19.03. | Filament Health Corp: Filament ships botanical psilocybin to four countries | 1 | Stockwatch | ||
19.03. | Filament Health Announces Shipments Of Botanical Psilocybin To Four Countries For Clinical Investigation | 1 | CNW | ||
15.02. | Filament Health Completes The First Export Of Botanical Psilocybin To Israel | 1 | CNW | ||
31.01. | Filament Health Corp: Filament receives FDA acceptance for IND application | 1 | Stockwatch | ||
31.01. | Filament Health Announces Fda Opening Of Investigational New Drug Application For Substance Use Disorders | 1 | CNW | ||
30.01. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions | 599 | ACCESSWIRE | Magdalena aiming to submit Investigational New Drug application in 2024 to the FDA for this next-generation psychoactive prescription drug candidate for potential mental health indications such as ADHD... ► Artikel lesen | |
17.01. | Filament Health Completes The First Export Of Botanical Psilocybin To Australia | 1 | CNW | ||
03.01. | Filament Health Announces Change To Board Of Directors | 1 | CNW | ||
03.01. | Filament Health Corp: Filament Health director O'Connell resigns | 1 | Stockwatch | ||
20.12.23 | Filament Health Walks Away From SPAC Merger, US$14.4 Million Financing | 1 | The Deep Dive | ||
20.12.23 | Jupiter Acquisition Mutually Terminates Merger Agreement with Filament Health | 1 | The SPAC Conference | ||
20.12.23 | Filament Health terminates proposed business combination with Jupiter Acquisition | 1 | Seeking Alpha | ||
20.12.23 | Filament Health Announces Termination Of Proposed Business Combination With Jupiter Acquisition Corporation | 1 | CNW | ||
20.12.23 | Jupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Public Shares | 189 | GlobeNewswire (Europe) | Hobe Sound, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) ("Jupiter") today announced the mutually agreed termination of the previously announced business combination... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 27,400 | +1,88 % | Bayer: Aufwärtskorrektur beginnt | Bei der Bayer-Aktie scheint das Schlimmste eingepreist zu sein. Zumindest kann sich der Aktienkurs stabilisieren und eine wichtige Trendlinie verteidigen. Wenn der Preis einer Aktie nicht mehr nachgibt... ► Artikel lesen | |
AURORA CANNABIS | 6,290 | +0,48 % | Aurora Cannabis & Canopy Growth: Deshalb ziehen sie an | Die Aurora Cannabis-Aktie (WKN: A2P4EC) und die Aktie von Canopy Growth (WKN: A140WQA) haben am Donnerstag plötzlich einen massiven Kurssprung von über +20% vollführt. Das steckt hinter dem rasanten... ► Artikel lesen | |
CANOPY GROWTH | 8,370 | +3,33 % | Spotlight on Canopy Growth: Analyzing the Surge in Options Activity | ||
TILRAY BRANDS | 1,670 | +2,08 % | Tilray Aktie: Achterbahnfahrt setzt sich fort | Zum Ende einer bewegten Woche notiert die Aktie des Unternehmens Tilray bei 1.62 €, was einer leichten Veränderung von -0.09% im Vergleich zur Vorwoche entspricht. Die Hoffnungen auf Lockerungen der... ► Artikel lesen | |
INNOCAN PHARMA | 0,186 | -1,85 % | Innocan Pharma leitet FDA-Zulassungsverfahren für Liposomen-Injektionstherapie gegen chronische Schmerzen ein | Mit der Übermittlung eines Antragsschreibens für ein Pre-IND-Meeting leitet Innocan das behördliche Zulassungsverfahren für seine Technologie der verzögerten
CBD-Freisetzung beim Menschen bei... ► Artikel lesen | |
CRONOS GROUP | 2,478 | +6,08 % | Cronos Group Inc: Cronos Group to hold Q1 2024 results call May 9 | ||
SYNBIOTIC | 9,660 | +4,32 % | ANLEIHEN-Woche KW16 - 2024: ABO Wind, SynBiotic, BIOGENA, Karlsberg, NEON EQUITY, Ekosem-Agrar, Huber Automotive, FCR Immobilien, DEMIRE, Dt. Bildung, Singulus, Eleving, Dt. Rohstoff, Bonds Monthly Income, … | Kalenderwoche 16 (15.04. - 19.04.2024) am KMU-Anleihemarkt - mit der NEON EQUITY AG beschließt das nächste Unternehmen die Emission einer Anleihe (ISIN DE000A383C76). Der neue Bond soll ein Volumen... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 11,590 | +5,27 % | Green Thumb Industries Inc: Green Thumb to open Rise Dispensary Wesley Chapel | ||
CHRISTINA LAKE CANNABIS | 0,019 | 0,00 % | Christina Lake Cannabis Corp.: Christina Lake Cannabis Provides Operations Update | VANCOUVER, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT:CLB), (the "Company" or "Christina Lake Cannabis" or "CLC"), a leading... ► Artikel lesen | |
AXSOME THERAPEUTICS | 66,52 | -0,36 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting | AXS-05 in Alzheimer's disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting... ► Artikel lesen | |
JAGUAR HEALTH | 0,163 | +3,69 % | Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care | Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called "chemo mouth") in Q3 2024Company to feature "Make Cancer Less Shitty" patient advocacy... ► Artikel lesen | |
JAZZ PHARMACEUTICALS | 102,00 | +1,85 % | Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community | Originally published by Jazz PharmaceuticalsNORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Purple Day spotlights epilepsy and the challenges that people face when living with the condition.Jazz wants... ► Artikel lesen | |
JUVA LIFE | 0,020 | -14,89 % | Juva Life Inc: Juva Life Unveils New Cannabis Vape Category - Rosin Absolute - Introduces Infused Flower Offerings and Announces Partnership With Cloudius9 | REDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Juva Life Inc. (CSE:JUVA)(OTCQB:JUVAF)(FRANKFURT:4VV) ("Juva Life" or the "Company"), Juva Life Inc, a life science company with both pharmaceutical... ► Artikel lesen | |
TRULIEVE CANNABIS | 9,915 | +4,81 % | Trulieve Cannabis Corp. - 8-K, Current Report | ||
CANNOVUM CANNABIS | 2,120 | +1,92 % | Cannabis-Aktien wie Cannovum, InnoCan & The Cannabist Company heben ab | Nicht nur die Canopy Growth-Aktie (WKN: A140QA) in den USA, auch einige deutsche Small Caps heben im Zuge des Cannabis-Rausches an der Börse seit einige Tagen ab. Was sollten Anleger jetzt mit Werten... ► Artikel lesen |